Showing results (101-110 of 463) with videos related to
Sort By:
Pageof 47
Brain : a Journal of Neurology|October 22, 2009
The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up studyCamiel Verhamme, Ivo N van Schaik, Johannes H T M Koelman, et al.Pain|August 20, 2016
Genetic variants associated with thermal pain sensitivity in a paediatric populationMaja Matic, Gerbrich E van den Bosch, Saskia N de Wildt, et al.Clinical Pharmacokinetics|March 10, 2018
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and PharmacogeneticsFemke M de Man, Andrew K L Goey, Ron H N van Schaik, et al.The Journal of Hand Surgery, European Volume|December 11, 2012
The long-term follow-up of treatment with corticosteroid injections in patients with carpal tunnel syndrome. When are multiple injections indicated?M Berger, M Vermeulen, J H T M Koelman, et al.Journal of Neuroimmunology|July 29, 2021
Virus discovery in chronic inflammatory demyelinating polyneuropathyG G A van Lieverloo, L Wieske, I N van Schaik, et al.American Journal of Hematology|August 29, 2007
UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell diseaseDeepika S Darbari, Ron H N van Schaik, Edmund V Capparelli, et al.The Cochrane Database of Systematic Reviews|January 11, 2022
Immunoglobulin for multifocal motor neuropathyStephen Keddie, Filip Eftimov, Leonard H van den Berg, et al.Journal of the Peripheral Nervous System : JPNS|May 9, 2017
Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case seriesMax E Adrichem, Markus V Starink, Ester M M van Leeuwen, et al.Pharmacogenomics|August 22, 2014
Calcineurin inhibitors and hypertension: a role for pharmacogenetics?Arthur D Moes, Dennis A Hesselink, Robert Zietse, et al.Journal of the Peripheral Nervous System : JPNS|May 4, 2022
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trialRobin van Veen, Luuk Wieske, Ilse Lucke, et al.Pageof 47